# Post-marketing Clinical Study of Alteplase for Acute Ischemic Stroke （Japan Alteplase Clinical Trial Ⅱ：J-ACT Ⅱ）

> **NCT00412867** · PHASE4 · COMPLETED · sponsor: **Tanabe Pharma Corporation** · enrollment: 58 (actual)

## Conditions studied

- Stroke

## Interventions

- **DRUG:** Alteplase

## Key facts

- **NCT ID:** NCT00412867
- **Lead sponsor:** Tanabe Pharma Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-12
- **Primary completion:** 2008-06
- **Final completion:** 2008-06
- **Target enrollment:** 58 (ACTUAL)
- **Last updated:** 2026-01-05

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00412867

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00412867, "Post-marketing Clinical Study of Alteplase for Acute Ischemic Stroke （Japan Alteplase Clinical Trial Ⅱ：J-ACT Ⅱ）". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT00412867. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*